Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1987-03-09
1989-08-15
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 514806, 530324, 530399, 530813, 530814, A61K 3702, A61K 3724, A61K 3736
Patent
active
048575054
ABSTRACT:
The invention relates to compositions comprising adducts of activated polysaccharides with biologically active growth hormones, somatomedins, growth factors and biologically active fragments. The invention also relates to a method for increasing and maintaining increased levels of these biologically active molecules in the blood of treated animals for extended periods of time, increasing weight gains in animals, and increasing milk production of lactating animals by the administration of a composition of the invention.
REFERENCES:
patent: 3947352 (1976-03-01), Cuatrecasas et al.
patent: 4003792 (1977-01-01), Mill et al.
patent: 4357423 (1982-11-01), Cox et al.
patent: 4521409 (1985-06-01), Bauman
patent: 4585754 (1986-04-01), Meisner et al.
American Cyanamid Company
Brennan Alice C.
Kight John
Nutter Nathan M.
LandOfFree
Sustained release compositions for parenteral administration and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release compositions for parenteral administration and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release compositions for parenteral administration and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-121670